Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.
As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.
The adoption of personal medical devices and healthcare kiosks that capture consumer health data — like blood pressure and glucose — coupled with data points with a patient’s health record at the pharmacy represents a significant opportunity to enhance disease state management programs.
The U.S. Hispanic population is projected to reach 128.8 million by 2060, or more than 30% of the U.S. population. This could bode especially well for purveyors of health products and services in the pharmacy setting.
Top Dog Direct is putting a lot of muscle behind its BeActive Brace. The brace, developed by a physical therapist, relieves tension up the sciatic nerve by providing firm trigger point acupressure from a patented pressure pad to the calf muscle.